Join the 'Attention Deficit Hyperactivity Disorder (ADHD)' group to help and get support from people like you.

Attention Deficit Hyperactivity Disorder (ADHD) Blog

Related terms: ADHD, Attention Deficit Disorder, Childhood hyperkinesis, ADD

Medication Linked to Fewer Injuries in Kids With ADHD

Posted 6 days ago by Drugs.com

MONDAY, Dec. 15, 2014 --Taking medication for attention-deficit hyperactivity disorder (ADHD) might reduce the risk of young patients accidentally injuring themselves, new research suggests. When several thousand children and teens were taking methylphenidate, which is marketed as Ritalin or Concerta in the United States, they were a little less likely to end up in the emergency room than when they weren't taking the drug, the study found. However, the report did not prove that taking ADHD medication prevented injuries. Past research has shown that children with ADHD are more likely to get injured, according to three of the study authors who jointly responded to questions. The authors are pharmacy professor Ian Wong and pediatrics professor Dr. David Coghill, both from The University of Hong Kong medical school, and epidemiologist Ian Douglas, from the London School of Hygiene and ... Read more

Related support groups: Attention Deficit Hyperactivity Disorder (ADHD), Concerta, Ritalin, Strattera, Methylphenidate, Methylin, Daytrana, Metadate CD, Ritalin LA, Methylin ER, Atomoxetine, Ritalin-SR, Quillivant XR, Metadate ER

Two Generic Versions of ADHD Drug Not as Effective: FDA

Posted 16 Nov 2014 by Drugs.com

FRIDAY, Nov. 14, 2014 – Two generic versions of the attention-deficit/hyperactivity disorder drug Concerta may not work as effectively as the brand-name product does, the U.S. Food and Drug Administration said Thursday. The agency analyzed available data and conducted laboratory tests on the two generic versions of Concerta (methylphenidate hydrochloride extended-release tablets) made by Mallinckrodt Pharmaceuticals and Kudco Ireland Ltd. The generic versions were approved by the FDA on the basis that they released the drug in the body over a period of 10 to 12 hours, to achieve the same effect as a three-times-per-day dose of immediate-release methylphenidate hydrochloride. But in some patients, the two generic versions may deliver the drug in the body at a slower rate. This slower release rate means the drug may be less effective, the FDA warned. Experts said the warning is ... Read more

Related support groups: Attention Deficit Hyperactivity Disorder (ADHD), Concerta, Ritalin, Methylphenidate, Methylin, Daytrana, Metadate CD, Ritalin LA, Methylin ER, Ritalin-SR, Quillivant XR, Metadate ER

FDA Concerns About Therapeutic Equivalence with Two Generic Versions of Concerta Tablets

Posted 13 Nov 2014 by Drugs.com

November 13, 2014 – Based on an analysis of data, FDA has concerns about whether or not two approved generic versions of Concerta tablets (methylphenidate hydrochloride extended-release tablets), used to treat attention-deficit hyperactivity disorder in adults and children, are therapeutically equivalent to the brand-name drug. The two approved generic versions of Concerta are manufactured by Mallinckrodt Pharmaceuticals and Kudco Ireland Ltd. As a result, the FDA has changed the therapeutic equivalence (TE) rating for the Mallinckrodt and Kudco products from AB to BX. This means the Mallinckrodt and Kudco products are still approved and can be prescribed, but are no longer recommended as automatically substitutable at the pharmacy (or by a pharmacist) for Concerta. Consequently, FDA has revised its draft guidance for industry for bioequivalence testing for methylphenidate ... Read more

Related support groups: Attention Deficit Hyperactivity Disorder (ADHD), Concerta, Methylphenidate

FDA Concerns About Therapeutic Equivalence with Two Generic Versions of Concerta Tablets

Posted 13 Nov 2014 by Drugs.com

November 13, 2014 – Based on an analysis of data, FDA has concerns about whether or not two approved generic versions of Concerta tablets (methylphenidate hydrochloride extended-release tablets), used to treat attention-deficit hyperactivity disorder in adults and children, are therapeutically equivalent to the brand-name drug. The two approved generic versions of Concerta are manufactured by Mallinckrodt Pharmaceuticals and Kudco Ireland Ltd. As a result, the FDA has changed the therapeutic equivalence (TE) rating for the Mallinckrodt and Kudco products from AB to BX. This means the Mallinckrodt and Kudco products are still approved and can be prescribed, but are no longer recommended as automatically substitutable at the pharmacy (or by a pharmacist) for Concerta. Consequently, FDA has revised its draft guidance for industry for bioequivalence testing for methylphenidate ... Read more

Related support groups: Attention Deficit Hyperactivity Disorder (ADHD), Concerta, Methylphenidate

FDA Concerns About Therapeutic Equivalence with Two Generic Versions of Concerta Tablets

Posted 13 Nov 2014 by Drugs.com

November 13, 2014 – Based on an analysis of data, FDA has concerns about whether or not two approved generic versions of Concerta tablets (methylphenidate hydrochloride extended-release tablets), used to treat attention-deficit hyperactivity disorder in adults and children, are therapeutically equivalent to the brand-name drug. The two approved generic versions of Concerta are manufactured by Mallinckrodt Pharmaceuticals and Kudco Ireland Ltd. As a result, the FDA has changed the therapeutic equivalence (TE) rating for the Mallinckrodt and Kudco products from AB to BX. This means the Mallinckrodt and Kudco products are still approved and can be prescribed, but are no longer recommended as automatically substitutable at the pharmacy (or by a pharmacist) for Concerta. Consequently, FDA has revised its draft guidance for industry for bioequivalence testing for methylphenidate ... Read more

Related support groups: Attention Deficit Hyperactivity Disorder (ADHD), Concerta, Methylphenidate

ADHD Stimulant Drug Abuse Common Among Young Adults: Survey

Posted 13 Nov 2014 by Drugs.com

THURSDAY, Nov. 13, 2014 – Nearly one in every five college students abuses prescription stimulants, according to a new survey sponsored by the Partnership for Drug-Free Kids. The survey also found that one in seven non-students of similar age also report abusing stimulant medications. Young adults aged 18 to 25 report using the drugs to help them stay awake, study or improve their work or school performance. The most commonly abused stimulants are those typically prescribed for attention-deficit/hyperactivity disorder (ADHD), such as Adderall, Ritalin and Vyvanse, the survey found. "The findings shed a new and surprising light on the young adult who is abusing prescription stimulants," said Sean Clarkin, director of strategy and program management for the Partnership for Drug-Free Kids. "While there is some 'recreational' abuse, the typical misuser is a male college student whose grade ... Read more

Related support groups: Attention Deficit Hyperactivity Disorder (ADHD), Adderall, Vyvanse, Concerta, Ritalin, Adderall XR, Methylphenidate, Methylin, Daytrana, Metadate CD, Ritalin LA, Amphetamine/Dextroamphetamine, Methylin ER, Lisdexamfetamine, Ritalin-SR, Metadate ER, Quillivant XR

ADHD Linked to Expectant Moms' Smog Exposure

Posted 5 Nov 2014 by Drugs.com

WEDNESDAY, Nov. 5, 2014 – Pregnant women exposed to air pollution are five times more likely to have children who develop behavior problems related to attention-deficit/hyperactivity disorder, or ADHD, a new study reports. A child's risk of ADHD symptoms by age 9 appears to increase dramatically if they were exposed in the womb to high levels of air pollutants called polycyclic aromatic hydrocarbons (PAHs), researchers at Columbia University reported. Compared to children with low PAH exposure, children exposed to high levels are more likely to have both an increased number of symptoms and more intense symptoms, said lead author Frederica Perera, a professor of environmental health sciences at Columbia's Mailman School of Public Health in New York City. Pollutants and other environmental factors likely interact with an unborn child's genetics to increase their risk of ADHD later in ... Read more

Related support groups: Attention Deficit Hyperactivity Disorder (ADHD)

Typical ADHD Care Leaves Room for Improvement, Study Finds

Posted 3 Nov 2014 by Drugs.com

MONDAY, Nov. 3, 2014 – Many pediatricians provide inadequate care for children with attention-deficit/hyperactivity disorder (ADHD), relying too heavily on drugs and failing to thoroughly assess kids' symptoms, a new study reports. Nearly one-third of pediatricians who diagnose children with ADHD do not consult the Diagnostic and Statistical Manual of Mental Disorders, a necessary step in determining if the kids meet the criteria for the brain disorder, researchers found. A large number of pediatricians also do not gather parent and teacher ratings of a child's day-to-day behavior, information that is crucial in diagnosing ADHD and tracking whether prescribed therapies are working, the study said. And finally, doctors appear to lean heavily on drugs for treating ADHD. Nine out of 10 kids with ADHD are on some sort of medication. But only one out of 10 kids is receiving behavioral ... Read more

Related support groups: Attention Deficit Hyperactivity Disorder (ADHD)

U.S. Kids Use ADHD Meds More During School Year

Posted 17 Oct 2014 by Drugs.com

FRIDAY, Oct. 17, 2014 – American children's use of stimulant medications is 30 percent higher during the school year than in the summer, a new study indicates. The findings suggest that many children may use stimulants to help them meet academic demands, according to the researchers. Stimulant medications improve concentration and help manage symptoms associated with attention-deficit/hyperactivity disorder (ADHD). They are the most widely used type of medication among teens, the researchers said. Currently, about 6 percent of U.S. children use stimulants, up from about 2.4 percent in 1996, the study authors noted. The current study included an analysis of prescriptions written for stimulants in the United States during the 2007 to 2008 school year. The study revealed that use of the drugs during school months is highest among children in wealthier families. Stimulant use during school ... Read more

Related support groups: Attention Deficit Hyperactivity Disorder (ADHD), Adderall, Concerta, Ritalin, Adderall XR, Methylphenidate, Methylin, Daytrana, Metadate CD, Ritalin LA, Amphetamine/Dextroamphetamine, Methylin ER, Ritalin-SR, Metadate ER, Quillivant XR

Health Tip: If Your Child's Grades Are Dropping

Posted 2 Oct 2014 by Drugs.com

-- If your child is suddenly struggling with school performance, the cause may be a physical health problem. The American Academy of Pediatrics says problems that may contribute to a drop in school performance include: Having a sleep disorder, anemia or a thyroid condition. Contracting infectious mononucleosis. Having hearing or vision problems. Having a learning or developmental disability, such as attention-deficit hyperactivity disorder (ADHD), dyslexia or a central auditory processing disorder. Having a substance abuse problem. Read more

Related support groups: Attention Deficit Hyperactivity Disorder (ADHD)

ADHD Can Hamper School Performance as Early as 2nd Grade, Study Says

Posted 29 Sep 2014 by Drugs.com

MONDAY, Sept. 29, 2014 – Attention-deficit/hyperactivity disorder can harm a child's academic performance and social skills as early as the second grade, a new Australian study contends. Children between 6 and 8 years old who were tested and scored high for ADHD symptoms were more likely to get lower grades in elementary school and have trouble fitting in with other kids, compared with children without ADHD, the study authors reported. Kids with ADHD also were more likely to have other mental health or developmental disorders, including anxiety, depression and autism, according to the study. "Already at this stage, which is relatively young, it's very clear the children have important functional problems in every domain we registered," said study lead author Dr. Daryl Efron, a developmental-behavioral pediatrician with the Royal Children's Hospital Melbourne. "On every measure, we ... Read more

Related support groups: Attention Deficit Hyperactivity Disorder (ADHD)

Many Kids With ADHD May Be Missing Out on Talk Therapy

Posted 25 Sep 2014 by Drugs.com

THURSDAY, Sept. 25, 2014 – Only one of four American children who has health insurance and has been prescribed medication to treat attention-deficit/hyperactivity disorder (ADHD) also receives some form of talk therapy, according to a new study. The findings raise concerns that doctors may just be prescribing pills for behavior problems, rather than targeting kids' specific difficulties through judicious use of medication and therapy, said lead author Dr. Walid Gellad, an adjunct scientist at RAND Corporation, a nonprofit research organization. "Drug therapy targets the core symptoms of ADHD, but when you talk about other aspects of functioning like educational performance and conduct problems, it appears that talk therapy may improve outcomes for many children," Gellad said. "In some kids, it is better than drug therapy alone," he added. Access to therapy is extremely restricted in ... Read more

Related support groups: Attention Deficit Hyperactivity Disorder (ADHD)

Kids Taking ADHD Drugs Get Little Psychotherapy: Study

Posted 23 Sep 2014 by Drugs.com

TUESDAY, Sept. 23, 2014 – Few children who take medication for attention-deficit/hyperactivity disorder (ADHD) also undergo behavioral therapy, and the rates vary six-fold across counties in the United States, a new study finds. Medication alone can manage symptoms for many children with ADHD, but some do better if they also receive behavioral therapy (psychotherapy), the Rand Corp. researchers noted. The researchers analyzed data in more than 1,500 counties across the United States that included more than 300,000 privately insured children, aged 17 and younger, who were prescribed ADHD drugs. Less than a quarter of them received any psychotherapy in the same year they took ADHD medications; 13 percent had at least four therapy visits, and seven percent had at least eight therapy sessions. In some counties, fewer than 10 percent of kids taking ADHD drugs got behavioral therapy, ... Read more

Related support groups: Attention Deficit Hyperactivity Disorder (ADHD)

Study Sees Differences in Brain Connections of Kids With ADHD

Posted 15 Sep 2014 by Drugs.com

MONDAY, Sept. 15, 2014 – Key connections between brain networks seem to mature more slowly in young people with attention deficit hyperactivity disorder (ADHD), according to a new study. These connections within and between certain brain networks control internally directed thought, such as daydreaming, and influence the ability to focus on external tasks. This slower development of these important connections could shed light on why those with ADHD are easily distracted or have trouble staying focused, the researchers said. "It is particularly noteworthy that the networks we found to have lagging maturation in ADHD are linked to the very behaviors that are the symptoms of ADHD," said the study's lead author, Dr. Chandra Sripada, an assistant professor and psychiatrist at the University of Michigan in Ann Arbor. The researchers said their findings might one day help doctors use brain ... Read more

Related support groups: Attention Deficit Hyperactivity Disorder (ADHD)

Medications Plus Parent Training May Help Kids With Aggression, ADHD

Posted 11 Sep 2014 by Drugs.com

THURSDAY, Sept. 11, 2014 – Combining two medications with parent training appears to improve anger, irritability and violent tendencies in children whose attention-deficit/hyperactivity disorder (ADHD) is coupled with severe aggression, a new study suggests. "Augmented" therapy that consists of stimulant and antipsychotic drugs, along with parent training in behavioral management techniques, was rated more effective by parents than "basic" therapy pairing only the stimulant and parent training, researchers found. "An important finding of this study was that at the end of nine weeks, approximately half of all children receiving basic therapy were still rated by their parents as being impaired... with symptoms interfering with school or social functioning," said study author Kenneth Gadow, a professor of psychiatry at Stony Brook University in New York. "In the augmented group receiving ... Read more

Related support groups: Attention Deficit Hyperactivity Disorder (ADHD), Concerta, Ritalin, Risperdal, Risperidone, Methylphenidate, Methylin, Daytrana, Metadate CD, Ritalin LA, Methylin ER, Risperdal Consta, Ritalin-SR, Risperdal M-Tab, Quillivant XR, Metadate ER

Page 1 2 3 ... Next

Ask a Question

Further Information

Related Condition Support Groups

Oppositional Defiant Disorder, Executive Function Disorder, Psychiatric Disorders

Related Drug Support Groups

Adderall, Vyvanse, Concerta, bupropion, Ritalin, clonidine, amphetamine, Adderall XR, Strattera, view more... Focalin, methylphenidate, methamphetamine, Focalin XR, Fish Oil, dextroamphetamine, Lovaza, Dexedrine, Intuniv, imipramine, Methylin, Daytrana, modafinil, guanfacine, 5-HTP, tryptophan, Desoxyn, selegiline, Kapvay, Metadate CD, Ritalin LA, amantadine, amphetamine / dextroamphetamine, desipramine, Methylin ER, atomoxetine, Omega-3, 5-hydroxytryptophan, desvenlafaxine, lisdexamfetamine, dexmethylphenidate, Ritalin-SR, pycnogenol, Dextrostat, Cylert, Omacor, armodafinil, ProCentra, Desoxyn Gradumet, omega-3 polyunsaturated fatty acids, MaxEPA, Animi-3, Metadate ER, Marine Lipid Concentrate, Quillivant XR, pemoline, Vascazen, TheraTears Nutrition, Omega 3-6-9 Complex, TherOmega, Divista, Liquadd, EPA Fish Oil, Omega-500, Proepa, Super-EPA, Sea-Omega, Sea-Omega 30, Sea-Omega 70, Selgene, Jumex, Atapryl, Carbex, Mi-Omega